chemomab.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Chemomab |
| Description | Pioneering Innovative Treatments for Patients with Fibrosis-Related |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.198.14.52 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
chemomab.com Valuation
|
US$5,955,757
Last updated: 2023-05-13 17:23:42
chemomab.com has Semrush global rank of 1,777,155. chemomab.com has an estimated worth of US$ 5,955,757, based on its estimated Ads revenue. chemomab.com receives approximately 687,203 unique visitors each day. Its web server is located in United States, with IP address 104.198.14.52. According to SiteAdvisor, chemomab.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,955,757 |
| Daily Ads Revenue | US$5,498 |
| Monthly Ads Revenue | US$164,929 |
| Yearly Ads Revenue | US$1,979,144 |
| Daily Unique Visitors | 45,814 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| chemomab.com. | A | 10800 | IP: 104.198.14.52 |
| chemomab.com. | NS | 86400 | NS Record: ns3.dtnt.info. |
| chemomab.com. | NS | 86400 | NS Record: ns1.dtnt.info. |
| chemomab.com. | NS | 86400 | NS Record: ns2.dtnt.info. |
| chemomab.com. | MX | 10800 | MX Record: 5 alt1.aspmx.l.google.com. |
| chemomab.com. | MX | 10800 | MX Record: 1 aspmx.l.google.com. |
| chemomab.com. | MX | 10800 | MX Record: 5 alt2.aspmx.l.google.com. |
| chemomab.com. | MX | 10800 | MX Record: 10 aspmx3.googlemail.com. |
| chemomab.com. | MX | 10800 | MX Record: 10 aspmx2.googlemail.com. |
| chemomab.com. | TXT | 10800 | TXT Record: v=DKIM1; k=rsa; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEA6r/uS5JTF8jmoHtskZOMXMiKqC9PzYsf1oTu2Krnrdshzw+hCPUwPjLi+Davg6uo80EX1ivhpJZJ8+35GRZx8SDUtHH3bl8yDj1a1AEKc7KNv+0gXygzoKdHUOAVOazUuee8gMKj1ujZYujg7/Gzmu2Ses17jxfs17GYUg72neFxRnqiTidGrFEFuOqj S4oMSAIknsgNjoGToX9qDf55Dc1zvPo8iE7NjmmRV+kc75qATqU8Ti0fSI94f+XyM7J+W27vqUU/NpT1r8GhxNuSVfBe3ajhCTKlCQcH8Uo8JktRX5oT8caE22WhyI5UZbf3rsUZ5XdjbkR5Atf03tNGlQIDAQAB |
| chemomab.com. | TXT | 10800 | TXT Record: google-site-verification=akxj_WJPNR_uhtluo20UxDsJEnT55ct1Onj86xTYzk0 |
| chemomab.com. | TXT | 10800 | TXT Record: v=spf1 include:_spf.google.com ~all |
| chemomab.com. | TXT | 10800 | TXT Record: v=DKIM1; k=rsa; p=MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEA6r/uS5JTF8jmoHtskZOMXMiKqC9PzYsf1oTu2Krnrdshzw+hCPUwPjLi+Davg6uo80EX1ivhpJZJ8+35GRZx8SDUtHH3bl8yDj1a1AEKc7KNv+0gXygzoKdHUOAVOazUuee8gM Kj1ujZYujg7/Gzmu2Ses17jxfs17GYUg72neFxRnqiTidGrFEFuOqjS4oMSAIknsgNjoGToX9qDf55Dc1zvPo8iE7NjmmRV+kc75qATqU8Ti0fSI94f+XyM7J+W27vqUU/NpT1r8GhxNuSVfBe3ajhCTKlCQcH8Uo8JktRX5oT8caE22WhyI5UZbf3rsUZ5XdjbkR5Atf03tNGlQIDAQAB |
HtmlToTextCheckTime:2023-05-13 17:23:42
| logo About R&D Pipeline Investors News Contact For Patients Primary Sclerosing Cholangitis Chemomab Pioneering Innovative Treatments for Patients with Fibrosis-Related Diseases Chemomab Therapeutics is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet need that involve Inflammation and fibrosis Our Vision Innovation Translating novel biological insights into long-term transformative treatments Evidence Driven Drug discovery and development that are built on a deep understanding of central fibrotic mediators and pathways Improving Lives Committed to improve the quality of life of patients suffering from seriously debilitating and life-threatening diseases Innovation & Discovery Chemomab discovered the key role of the soluble chemokine CCL24 in promoting liver, skin and lung fibrosis. The Challenge Fibrosis-related diseases are a significant unmet need that dramatically affect patients health and quality of life. Damaged |
HTTP Headers
HTTP/1.1 301 Moved Permanently cache-control: public, max-age=0, must-revalidate content-length: 36 content-type: text/plain date: Tue, 21 Dec 2021 15:45:17 GMT x-nf-request-id: 01FQF8YJTCB8YDWBXGS4KWDKBJ location: https://chemomab.com/ server: Netlify age: 14955 HTTP/2 301 cache-control: public, max-age=0, must-revalidate content-length: 40 content-type: text/plain date: Tue, 21 Dec 2021 15:45:17 GMT strict-transport-security: max-age=31536000 server: Netlify location: https://www.chemomab.com/ x-nf-request-id: 01FQF8YK4A1WJKX2YVMS9WYNVD age: 14955 HTTP/2 200 cache-control: public, max-age=0, must-revalidate content-type: text/html; charset=UTF-8 date: Tue, 21 Dec 2021 14:32:36 GMT etag: "302813116a01a82b22062a2655a7578a-ssl" strict-transport-security: max-age=31536000 content-length: 35198 age: 19317 server: Netlify x-nf-request-id: 01FQF8YKEK4429A0E6SJWFCEAD |
chemomab.com Whois Information
Domain Name: CHEMOMAB.COM Registry Domain ID: 1693372805_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domainthenet.com Registrar URL: http://www.DomainTheNet.com Updated Date: 2021-10-24T07:04:08Z Creation Date: 2011-12-22T16:04:55Z Registry Expiry Date: 2022-12-22T16:04:55Z Registrar: Domain The Net Technologies Ltd. Registrar IANA ID: 10007 Registrar Abuse Contact Email: abuse@dtnt.com Registrar Abuse Contact Phone: 972-3-7600500 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.DTNT.INFO Name Server: NS2.DTNT.INFO Name Server: NS3.DTNT.INFO DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T07:27:19Z <<< |